Drawing for POZENTIA

USPTO serial 86972425

POZENTIA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
—
Law office
NEW APPLICATION PROCESSING

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with POZENTIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori S. Meddings

LORI S. MEDDINGS MICHAEL BEST & FRIEDRICH LLP100 EAST WISCONSIN AVENUE, SUITE 3300MILWAUKEE, WI 53202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 19, 2016MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT—
Jul 19, 2016ABN1ABANDONMENT - EXPRESS MAILED—
Jul 18, 2016EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Apr 15, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 15, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance